These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 10942180

  • 1. Evaluation of caffeine as an in vivo probe for CYP1A2 using measurements in plasma, saliva, and urine.
    Carrillo JA, Christensen M, Ramos SI, Alm C, Dahl ML, Benitez J, Bertilsson L.
    Ther Drug Monit; 2000 Aug; 22(4):409-17. PubMed ID: 10942180
    [Abstract] [Full Text] [Related]

  • 2. Analysis of urinary caffeine metabolites to assess biotransformation enzyme activities by reversed-phase high-performance liquid chromatography.
    Krul C, Hageman G.
    J Chromatogr B Biomed Sci Appl; 1998 May 08; 709(1):27-34. PubMed ID: 9653923
    [Abstract] [Full Text] [Related]

  • 3. Five caffeine metabolite ratios to measure tobacco-induced CYP1A2 activity and their relationships with urinary mutagenicity and urine flow.
    Sinués B, Sáenz MA, Lanuza J, Bernal ML, Fanlo A, Juste JL, Mayayo E.
    Cancer Epidemiol Biomarkers Prev; 1999 Feb 08; 8(2):159-66. PubMed ID: 10067814
    [Abstract] [Full Text] [Related]

  • 4. Influence of the urine flow rate on some caffeine metabolite ratios used to assess CYP1A2 activity.
    Sinués B, Fanlo A, Bernal ML, Mayayo E, Soriano MA, Martínez-Ballarin E.
    Ther Drug Monit; 2002 Dec 08; 24(6):715-21. PubMed ID: 12451287
    [Abstract] [Full Text] [Related]

  • 5. Caffeine metabolic ratios for the in vivo evaluation of CYP1A2, N-acetyltransferase 2, xanthine oxidase and CYP2A6 enzymatic activities.
    Hakooz NM.
    Curr Drug Metab; 2009 May 08; 10(4):329-38. PubMed ID: 19519341
    [Abstract] [Full Text] [Related]

  • 6. [Determination of caffeine metabolite for the evaluation of N-acetyltransferase, CYP1A2 and xanthine oxidase activities].
    Lu JF, Yi T, Cao XM, Zhuo HT, Ling SS.
    Yao Xue Xue Bao; 1997 Nov 08; 32(11):813-8. PubMed ID: 11596199
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Segregation analyses of four urinary caffeine metabolite ratios implicated in the determination of human acetylation phenotypes.
    Vincent-Viry M, Pontes ZB, Gueguen R, Galteau MM, Siest G.
    Genet Epidemiol; 1994 Nov 08; 11(2):115-29. PubMed ID: 8013893
    [Abstract] [Full Text] [Related]

  • 9. In vivo evaluation of CYP1A2, CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios.
    Begas E, Kouvaras E, Tsakalof A, Papakosta S, Asprodini EK.
    Biomed Chromatogr; 2007 Feb 08; 21(2):190-200. PubMed ID: 17221922
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Caffeine as a probe for CYP1A2 activity: potential influence of renal factors on urinary phenotypic trait measurements.
    Tang BK, Zhou Y, Kadar D, Kalow W.
    Pharmacogenetics; 1994 Jun 08; 4(3):117-24. PubMed ID: 7920691
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Correlation between assessment of cytochrome P450 1A2 activity and enzyme activity scores, and their relation to clozapine exposure.
    Alarcan H, Cannet P, Camus V, Fond G, Zendjidjian X, Guilhaumou R, Quaranta S.
    Br J Clin Pharmacol; 2023 May 08; 89(5):1665-1671. PubMed ID: 36507652
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dietary effects of Sideritis scardica "mountain tea" on human in vivo activities of xenobiotic metabolizing enzymes in healthy subjects.
    Begas E, Kilindris T, Kouvaras E, Tsioutsioumi A, Kouretas D, Asprodini EK.
    Food Chem Toxicol; 2018 Dec 08; 122():38-48. PubMed ID: 30266316
    [Abstract] [Full Text] [Related]

  • 16. Cytochrome P450 2A6 Phenotyping Using Dietary Caffeine Salivary Metabolite Ratios and Genotyping Using Blood on Storage Cards in Non-smoking Japanese Volunteers.
    Murayama N, Shimizu M, Kobayashi K, Kishimoto I, Yamazaki H.
    Drug Metab Lett; 2017 Dec 08; 10(4):240-243. PubMed ID: 27842485
    [Abstract] [Full Text] [Related]

  • 17. Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities.
    Relling MV, Lin JS, Ayers GD, Evans WE.
    Clin Pharmacol Ther; 1992 Dec 08; 52(6):643-58. PubMed ID: 1458773
    [Abstract] [Full Text] [Related]

  • 18. Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities.
    Fuchs P, Haefeli WE, Ledermann HR, Wenk M.
    Eur J Clin Pharmacol; 1999 Jan 08; 54(11):869-76. PubMed ID: 10027663
    [Abstract] [Full Text] [Related]

  • 19. Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: insights into the measurement of hepatic cytochrome P450 1A2 induction.
    Abraham K, Geusau A, Tosun Y, Helge H, Bauer S, Brockmöller J.
    Clin Pharmacol Ther; 2002 Aug 08; 72(2):163-74. PubMed ID: 12189363
    [Abstract] [Full Text] [Related]

  • 20. Polymorphisms of CYP1A2 and CYP2A6 activity: phenotypes and the effect of age and sex in a Nigerian population.
    Adehin A, Bolaji OO.
    Drug Metab Pers Ther; 2015 Sep 08; 30(3):203-10. PubMed ID: 26098700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.